Cancer cell movement during metastasis is a dynamic process regulated by several different signals. However, the way cells receive, process and respond to these signals has been extremely hard to ...

Announcing a new publication for Acta Materia Medica journal. Treatment of cancer can be challenging, because of the disease's intricate and varied nature. Consequently, developing nanomedicines with ...

Microscopy image of invasive breast cancer cells (labelled in yellow) degrading their underlying extracellular matrix (labelled gelatin in red, degraded areas appear as black holes). Scale bar, 20µm.

MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced completion of patient enrollment in the company’s Phase 2, ...

Consumer Wearable Device Measures of Gait Cadence and Activity Fragmentation as Predictors of Survival Among Patients Undergoing Chemotherapy Endocrine treatments for patients with hormone-sensitive ...

In the dynamic field of oncology, the quest for precise biomarkers to predict cancer risk, prognosis, and treatment response is paramount. These insights directly inform personalized therapeutic ...

Research shows people with color blindness face higher bladder cancer mortality because early blood-in-urine warning signs may go unnoticed.

Endocrine treatments for patients with hormone-sensitive breast cancer are associated with significant side effects that can negatively affect health-related quality of life and result in treatment ...